Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Whitehawk Therapeutics Inc WHWK

Healthcare Biotechnology
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:WHWK)

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer

PR Newswire December 1, 2025

Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

PR Newswire November 26, 2025

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

PR Newswire November 11, 2025

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

PR Newswire November 6, 2025

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC

PR Newswire October 24, 2025

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

PR Newswire September 2, 2025

Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

PR Newswire August 7, 2025

Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

PR Newswire July 22, 2025

Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series

PR Newswire June 19, 2025
View More News ››

Opinion & Analysis (NDAQ:WHWK)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:WHWK)

Aadi Bioscience (NASDAQ:AADI) &#8211; Unlocking the Full Pot

https://beyondspx.com/article/aadi-bioscience-nasdaqaadi-unlocking-the-full-potential-of-mtor-inhibition
MikeTester - January 22, 2025

ZACKS NEW #1 STRONGEST BUY

Better than expected earnings expected and is currently a Zack's STRONG buy. Price target of 40% upside.    READ THE...
yorgosGK - April 16, 2020
View more Bullboard ››

Playboy Inc.

Playboy Inc.

Playboy, Inc. operates as a pleasure and leisure company in the United States, Australia, China, the United Kingdom, and ...
View More »

Podcasts